As expected, EUR APOE4+ individuals had higher Braak stages than EUR APOE4−, even after adjusting for global ancestry; interestingly, the CDR-SOB scores were similar for both groups, even after adjusting for the burden of AD-pathology. This evidence concerns the gene APOE and Alzheimer disease.